CompletedPhase 2NCT01379625
Study of Triheptanoin for Treatment of Long-Chain Fatty Acid Oxidation Disorder
Studying Carnitine palmitoyltransferase II deficiency
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Oregon Health and Science University
- Principal Investigator
- Melanie B Gillingham, PhD, PhD, RDOregon Health and Science University
- Intervention
- Triheptanoin(drug)
- Enrollment
- 32 enrolled
- Eligibility
- 7 years · All sexes
- Timeline
- 2011 – 2015
Study locations (2)
- Oregon Health & Science University, Portland, Oregon, United States
- University of Pittsburgh, Pittsburgh, Pennsylvania, United States
Collaborators
University of Pittsburgh
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT01379625 on ClinicalTrials.gov